Human Reproduction, Vol 13, 3045-3048, Copyright © 1998 by Oxford University Press
G Horne, A Jamaludin, JD Critchlow, DA Falconer, MC Newman, J Oghoetuoma, EH Pease and BA Lieberman
Insemination with donor spermatozoa is an integral part of infertility
treatment. For the last 3 years in our unit, intrauterine insemination with
donor spermatozoa (IUID) has been used in preference to vaginal
insemination. In this retrospective study, patients were offered an initial
course of five single intrauterine inseminations with cryopreserved donor
spermatozoa and treatment was then reviewed. A total of 389 patients
received 1465 inseminations. In all, 1119 cycles were monitored using
luteinizing hormone serum analyses and 346 cycles using the urine home test
kits. The clinical pregnancy rate per insemination for the cycles monitored
by the serum assay was 18.0% (202/1119) compared with the urine cycles
(13.7%, 46/346) (P <05). The pregnancy loss rate was not significantly
different (14.4%, 29/202 and 21.7%, 10/46) (serum and urine cycles
respectively). The viable clinical pregnancy rate was significantly higher
(P <03) for the serum cycles than for the cycles using the urinary
monitoring (15.5%, 173/1119 and 10.4%, 36/346 respectively). The cycles
monitored by serum assay had a significantly higher cumulative viable
clinical pregnancy rate (P <0001) of 70.2% after nine inseminations
compared with the urine monitored cycles of 54.8%. The majority of patients
opted for the serum cycles, with a minority self-selecting the urine cycles
mainly for travelling convenience. The explanation for the significant
differences between the viable clinical pregnancy rates per insemination
and the cumulative viable clinical pregnancy rates may be due to the
sensitivity of the urine home test kit or the patients' interpretation of
the result.
ARTICLES
A 3 year retrospective review of intrauterine insemination, using cryopreserved donor spermatozoa and cycle monitoring by urinary or serum luteinizing hormone measurements
Department of Reproductive Medicine, St Mary's Hospital, Manchester, UK.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. F. Khattab, F. A. Mustafa, and P. J. Taylor The use of urine LH detection kits to time intrauterine insemination with donor sperm Hum. Reprod., September 1, 2005; 20(9): 2542 - 2545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Horne, A. Atkinson, D.R. Brison, J. Radford, J.A.L. Yin, E.C.O. Edi-Osagie, E.H.E. Pease, and B.A. Lieberman Achieving pregnancy against the odds: successful implantation of frozen-thawed embryos generated by ICSI using spermatozoa banked prior to chemo/radiotherapy for Hodgkin's disease and acute leukaemia: Case Report Hum. Reprod., January 1, 2001; 16(1): 107 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Garcia-Velasco, A. Arici, T. G. Zreik, and A. O. Awonuga Endogenous LH surge detection versus administration of HCG to correctly time intrauterine insemination: which provides a better pregnancy rate? Hum. Reprod., April 1, 2000; 15(4): 975 - 976. [Full Text] [PDF]
|
|
|
|
|
|
H. Lashen, M. Afnan, and A. Kennefik Early resort to ovarian stimulation improves the cost-effectiveness of a donor insemination programme Hum. Reprod., August 1, 1999; 14(8): 1983 - 1988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Awonuga and J. Govindbhai Is waiting for an endogenous luteinizing hormone surge and/or administration of human chorionic gonadotrophin of benefit in intrauterine insemination? Hum. Reprod., July 1, 1999; 14(7): 1765 - 1770. [Abstract] [Full Text] [PDF]
|
|